Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study

医学 肺活量测定 优势比 横断面研究 人口 肺功能测试 肺活量 支气管扩张剂 气道 环境卫生 内科学 哮喘 麻醉 肺功能 病理 扩散能力
作者
Dan Xiao,Zhengming Chen,Sinan Wu,Kewu Huang,Jianying Xu,Lan Yang,Yongjian Xu,Xiangyan Zhang,Chunxue Bai,Jian Kang,Pixin Ran,Huahao Shen,Fuqiang Wen,Wan-zhen Yao,Tieying Sun,Guangliang Shan,Ting Yang,Yingxiang Lin,Jianguo Zhu,Ruiying Wang
出处
期刊:The Lancet Respiratory Medicine [Elsevier BV]
卷期号:8 (11): 1081-1093 被引量:186
标识
DOI:10.1016/s2213-2600(20)30155-7
摘要

Background Small airway dysfunction is a common but neglected respiratory abnormality. Little is known about its prevalence, risk factors, and prognostic factors in China or anywhere else in the world. We aimed to estimate the prevalence of small airway dysfunction using spirometry before and after bronchodilation, both overall and in specific population subgroups; assess its association with a range of lifestyle and environmental factors (particularly smoking); and estimate the burden of small airway dysfunction in China. Methods From June, 2012, to May, 2015, the nationally representative China Pulmonary Health study invited 57 779 adults to participate using a multistage stratified sampling method from ten provinces (or equivalent), and 50 479 patients with valid lung function testing results were included in the analysis. We diagnosed small airway dysfunction on the basis of at least two of the following three indicators of lung function being less than 65% of predicted: maximal mid-expiratory flow, forced expiratory flow (FEF) 50%, and FEF 75%. Small airway dysfunction was further categorised into pre-small airway dysfunction (defined as having normal FEV1 and FEV1/forced vital capacity [FVC] ratio before bronchodilator inhalation), and post-small airway dysfunction (defined as having normal FEV1 and FEV1/FVC ratio both before and after bronchodilator inhalation). Logistic regression yielded adjusted odds ratios (ORs) for small airway dysfunction associated with smoking and other lifestyle and environmental factors. We further estimated the total number of cases of small airway dysfunction in China by applying present study findings to national census data. Findings Overall the prevalence of small airway dysfunction was 43·5% (95% CI 40·7–46·3), pre-small airway dysfunction was 25·5% (23·6–27·5), and post-small airway dysfunction was 11·3% (10·3–12·5). After multifactor regression analysis, the risk of small airway dysfunction was significantly associated with age, gender, urbanisation, education level, cigarette smoking, passive smoking, biomass use, exposure to high particulate matter with a diameter less than 2·5 μm (PM2·5) concentrations, history of chronic cough during childhood, history of childhood pneumonia or bronchitis, parental history of respiratory diseases, and increase of body-mass index (BMI) by 5 kg/m2. The ORs for small airway dysfunction and pre-small airway dysfunction were similar, whereas larger effect sizes were generally seen for post-small airway dysfunction than for either small airway dysfunction or pre-small airway dysfunction. For post-small airway dysfunction, cigarette smoking, exposure to PM2·5, and increase of BMI by 5 kg/m2 were significantly associated with increased risk, among preventable risk factors. There was also a dose-response association between cigarette smoking and post-small airway dysfunction among men, but not among women. We estimate that, in 2015, 426 (95% CI 411–468) million adults had small airway dysfunction, 253 (238–278) million had pre-small airway dysfunction, and 111 (104–126) million had post-small airway dysfunction in China. Interpretation In China, spirometry-defined small airway dysfunction is highly prevalent, with cigarette smoking being a major modifiable risk factor, along with PM2·5 exposure and increase of BMI by 5 kg/m2. Our findings emphasise the urgent need to develop and implement effective primary and secondary prevention strategies to reduce the burden of this condition in the general population. Funding Ministry of Science and Technology of China; National Natural Science Foundation of China; National Health Commission of China.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
淡然雁梅完成签到 ,获得积分10
6秒前
10秒前
游01完成签到 ,获得积分0
10秒前
10秒前
白白不喽完成签到 ,获得积分10
12秒前
科研爱好者完成签到,获得积分10
14秒前
俞俊敏发布了新的文献求助10
14秒前
DY完成签到,获得积分10
18秒前
鹿鹿完成签到,获得积分10
20秒前
于洋完成签到 ,获得积分10
21秒前
传奇3应助xzgwbh采纳,获得10
23秒前
都都完成签到 ,获得积分10
24秒前
冰蓝色的忧伤完成签到,获得积分10
32秒前
畅快的信封完成签到,获得积分10
33秒前
35秒前
LJ_2完成签到 ,获得积分0
38秒前
鲤鱼寻菡完成签到 ,获得积分10
44秒前
付其喜完成签到 ,获得积分10
46秒前
乐观的箭头完成签到,获得积分10
48秒前
又壮了完成签到 ,获得积分10
48秒前
shmilycaleb完成签到,获得积分10
51秒前
LYB完成签到 ,获得积分10
52秒前
崩溃完成签到,获得积分10
57秒前
大脸猫完成签到 ,获得积分10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
Orange应助科研通管家采纳,获得10
1分钟前
Mois完成签到 ,获得积分10
1分钟前
lyb完成签到 ,获得积分10
1分钟前
木木三完成签到 ,获得积分10
1分钟前
向光而行完成签到 ,获得积分10
1分钟前
xiaoxiao31996发布了新的文献求助10
1分钟前
乘凉完成签到,获得积分10
1分钟前
1分钟前
科研顺利完成签到,获得积分10
1分钟前
感性的俊驰完成签到 ,获得积分10
1分钟前
1分钟前
笨笨完成签到 ,获得积分10
1分钟前
Akim应助xiaoxiao31996采纳,获得10
1分钟前
小天使海蒂完成签到 ,获得积分10
1分钟前
zhaoyang完成签到 ,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Picture this! Including first nations fiction picture books in school library collections 1500
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
CLSI M100 Performance Standards for Antimicrobial Susceptibility Testing 36th edition 400
Cancer Targets: Novel Therapies and Emerging Research Directions (Part 1) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6362250
求助须知:如何正确求助?哪些是违规求助? 8175908
关于积分的说明 17224411
捐赠科研通 5416933
什么是DOI,文献DOI怎么找? 2866654
邀请新用户注册赠送积分活动 1843775
关于科研通互助平台的介绍 1691587